Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-005416

Director sold 345,000 shares at $26.50 ($9,142,500)

  • Director acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ZOLTNERS ANDRIS A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-28 Exercise or conversion : show line 1 in the form +100,000 $0.16 $16,000 3,966,016 D
2020-01-28 Sale : show line 2 in the form −345,000 $26.50 $9,142,500 3,621,016 D
Open-market sales · 345,000 sh · avg $26.50 · $9,142,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-01-28 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −100,000 0 D
Loading xslF345X03/doc4.xml…